Resistance mutations found in those receiving GSK and Vir’s monoclonal for Delta, new research shows

While the Delta variant is in the rearview mirror now, new research from Australia shows how some people developed sotrovimab-resistant mutations following infusions with the GlaxoSmithKline and Vir monoclonal antibody when they were sick with Covid-19.